Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques.
Antiviral
Cognitive function
Emotional reactivity
Motor function
Prophylaxis
Social behavior
Journal
Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498
Informations de publication
Date de publication:
15 08 2023
15 08 2023
Historique:
received:
22
04
2023
revised:
25
06
2023
accepted:
06
07
2023
pmc-release:
15
08
2024
medline:
16
8
2023
pubmed:
15
7
2023
entrez:
14
7
2023
Statut:
ppublish
Résumé
Zika virus (ZIKV) infection during infancy in a rhesus macaque (RM) model negatively impacts brain development resulting in long-term behavioral alterations. The current study investigated whether postexposure prophylaxis could alleviate these negative neurodevelopmental consequences. Three RM infants received a 14-day course of sofosbuvir (SOF; 15 mg/kg p.o.) treatment starting at 3 days post-infection with a Puerto Rican strain of ZIKV (PRVABC59) and were then monitored longitudinally for one year. In contrast to ZIKV-infected infant RMs who did not receive SOF, postexposure SOF treatment mitigated the neurodevelopmental, behavioral and cognitive changes seen after postnatal ZIKV infection even while not accelerating viral clearance from the blood. These data suggest that antiviral treatment may help ameliorate some, but not all, of the neurodevelopmental abnormalities associated with early postnatal ZIKV infection.
Identifiants
pubmed: 37451078
pii: S0165-5728(23)00134-0
doi: 10.1016/j.jneuroim.2023.578148
pmc: PMC10528946
mid: NIHMS1919232
pii:
doi:
Substances chimiques
Sofosbuvir
WJ6CA3ZU8B
Antiviral Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
578148Subventions
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS120182
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.
Références
Sci Transl Med. 2018 Apr 4;10(435):
pubmed: 29618564
Sci Rep. 2017 Aug 25;7(1):9409
pubmed: 28842610
Rev Soc Bras Med Trop. 2016 Sep-Oct;49(5):553-558
pubmed: 27812648
Sci Rep. 2017 Jan 18;7:40920
pubmed: 28098253
J Neurosci. 2019 Jul 3;39(27):5393-5403
pubmed: 31085612
Paediatr Perinat Epidemiol. 2017 Nov;31(6):537-545
pubmed: 28806479
Cell. 2017 May 4;169(4):610-620.e14
pubmed: 28457610
MMWR Morb Mortal Wkly Rep. 2018 Mar 09;67(9):265-269
pubmed: 29518067
J Neurosci. 2016 Aug 17;36(33):8746-56
pubmed: 27535919
Nat Commun. 2016 Jun 28;7:12204
pubmed: 27352279
Lancet Infect Dis. 2020 Mar;20(3):371-380
pubmed: 31870907
N Engl J Med. 2016 Mar 10;374(10):951-8
pubmed: 26862926
N Engl J Med. 2020 Aug 6;383(6):e44
pubmed: 27305043
Front Neuroinform. 2014 Feb 06;8:7
pubmed: 24567717
Hippocampus. 2010 Aug;20(8):922-35
pubmed: 19739247
Antiviral Res. 2017 Jan;137:134-140
pubmed: 27902933
J Comp Neurol. 2019 Dec 15;527(18):3034-3045
pubmed: 31173365
Nat Med. 2016 Dec;22(12):1448-1455
pubmed: 27694931
Science. 1988 Nov 4;242(4879):741-5
pubmed: 3055294
Med Mal Infect. 2014 Jul;44(7):302-7
pubmed: 25001879
Hippocampus. 2014 Jul;24(7):794-807
pubmed: 24648155
Am J Med Genet A. 2017 Apr;173(4):841-857
pubmed: 28328129
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Antiviral Res. 2019 Jul;167:104-109
pubmed: 31051186
N Engl J Med. 2017 Feb 14;379(13):1234-1243
pubmed: 28195756
Int J Infect Dis. 2020 Jan;90:104-110
pubmed: 31678190
Front Neurosci. 2017 Jan 10;10:617
pubmed: 28119564
BMJ. 2016 Apr 13;353:i1901
pubmed: 27075009
Clin Infect Dis. 2018 Mar 19;66(7):1120-1121
pubmed: 29300859
MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1343-1348
pubmed: 27906905
Science. 1988 Apr 8;240(4849):167-71
pubmed: 3353713
Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):26210-26216
pubmed: 31871159
PLoS One. 2022 Jul 14;17(7):e0266664
pubmed: 35834540
Cereb Cortex. 2014 Jan;24(1):17-36
pubmed: 23010748
AJNR Am J Neuroradiol. 2017 Jul;38(7):1427-1434
pubmed: 28522665
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):858-867
pubmed: 30091967
Antiviral Res. 2020 Oct;182:104859
pubmed: 32649965
Paediatr Perinat Epidemiol. 2021 Jan;35(1):92-97
pubmed: 32488915
MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):242-7
pubmed: 26963593
Trop Med Int Health. 2021 Jan;26(1):66-81
pubmed: 33151584
Nat Commun. 2020 May 21;11(1):2534
pubmed: 32439858
Behav Neurosci. 2010 Dec;124(6):742-60
pubmed: 21133531
Antiviral Res. 2017 Oct;146:161-163
pubmed: 28912011
Sci Rep. 2018 Jan 19;8(1):1218
pubmed: 29352135